SMTL ID : 5enn.1 (1 other biounit)

The crystal structure of Human VPS34 in complex with a selective and potent inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.70 Å

Oligo State

monomer

Ligands

1 x 5QS: 1-[[4-(cyclopropylmethyl)-5-[2-(pyridin-4-ylamino)pyrimidin-4-yl]pyrimidin-2-yl]amino]-2-methyl-propan-2-ol(Non-covalent)

5QS.1: 14 residues within 4Å: Chain A: F.350, S.352, I.372, K.374, Y.408, M.420, Q.421, F.422, I.423, S.425, P.427, L.488, I.498, D.499 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:F.350, A:K.374, A:F.422, A:L.488 Hydrogen bonds: A:K.374, A:Y.408, A:I.423, A:I.423, A:D.499 Water bridges: A:D.382, A:D.499 pi-Stacking: A:Y.408

1 x NA: SODIUM ION(Non-functional Binders)

NA.2: 1 residues within 4Å: Chain A: P.407 2 PLIP interactions: 2 interactions with chain A Water bridges: A:P.407, A:Q.421

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Kearney, E.P., Potent, selective, and orally bioavailable inhibitors of VPS34 provide chemical tools to modulate autophagy in vivo. To Be Published

Release Date

2016-11-16

Peptides

Phosphatidylinositol 3-kinase catalytic subunit type 3: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Phosphatidylinositol 3-kinase catalytic subunit type 3

Related Entries With Identical Sequence